Legal Issues and BPCI Act

The legal issues pertaining to the the follow-on-biologics and biosimilars are one of the most aspects that requires an open discussion. Before the actual advent of biosimilars to the market legal issues have risen in numbers in their developmental stages. Renowned organizations have filed cases against each other two claim their rights and for other legal allegations related to the products. This track is dedicated to discussion of all such cases which has been argued in the court of law.

By 2002, the FDA had approved 36 new biologics, followed by 37 more in 2003, another 40 in 2004 and 39 more in 2005. By 2006, the leading category of biologic treatment, the red blood cell enhancer recombinant erythropoietin (EPO), generated $14 billion in sales revenues, or 40 percent more than the best-selling traditional pharmaceutical, Lipitor. More than 300 therapeutic antibodies currently are in clinical development and trials, compared to just 13 that already are widely available due to legal issues.

  • Implimentation of the BPCI Act
  • Patent protection and infringement issues
  • Patent negotiation and litigation phase
  • Market exclusivities

Related Conference of Legal Issues and BPCI Act

April 20-21, 2018

4th International Conference on Antibiotics: R&D, B2B

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

15th Annual European Pharma Congress

Frankfurt, Germany
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
June 27-28, 2018

International Conference on Pharmaceutical Analysis and Quality Control Strategies

Vancouver, British Columbia, Canada
July 16-17, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 18-20, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
August 15-17, 2018

14th World Congress on Pharmacology and Drug Safety

Stockholm, Sweden
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 14-15, 2018

Annual Neurochemistry and Neuropharmacology Congress

Richmond, Virginia, USA
September 17-18, 2018

5th International Conference on Clinical Pharmacy and Pharmacy Practice

San Antonio, Texas, USA
September 17-18, 2018 | San Antonio, Texas, USA

11th World Congress on Pharmacology & Therapeutics

September 17-18, 2018

Annual Pharmacy and Pharmaceutical Science Conference

Kuala Lumpur, Malaysia
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 17-18, 2018

Drug formulation Congress 2018

Singapore
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 24-25, 2018

Pharmacoepidemiology 2018

Dubai, UAE
September 28-29, 2018

13th World Congress on Pharmaceutical Sciences

| Montreal, Canada
September 24-25, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
October 22-23, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
August 24-25, 2018

7th Global Advances in Mass Spectrometry

Singapore
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
Oct 31- Nov 01, 2018

34th International Conference on Pharmaceuticals & Nutraceuticals

San Francisco, California, USA
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Frankfurt, Germany

Legal Issues and BPCI Act Conference Speakers

Recommended Sessions

Related Journals

Are you interested in